|
|
|
| home > pmps > autumn 2021 > eight key benefits to automation for pharma manufacturing |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Investing in automation and robotics technology can result in a
wide range of benefits for businesses within pharma manufacturing,
including improvements in efficiency, safety, and overall performance.
Importantly, automated trucks and warehouse systems can also bring about
significant cost savings, as well as help to reduce carbon emissions
throughout the supply chain.
As one of the
most rapidly advancing industries, we’ve seen automation developing at
speed within the pharma sector. We’re seeing increasing demand from
clients across the industry looking to keep up with latest innovations
and technologies to ensure they can compete with rising demand and
ever-tightening clinical development deadlines. Meeting this demand is
essential; businesses that are unable to keep up risk falling behind
competitors.
The past year has shone a
light on the pharma industry and its global supply chain, and has
brought about rapid change in how the industry operates. Those pressures
brought on by the pandemic – such as shifting to new working practices,
reduced workforce numbers due to social distancing and illness, and the
implementation of additional hygiene measures to safeguard employee
health, among many others – has made it necessary for manufacturers to
adapt their operations across the board.
These
changes have led to an accelerated adoption of new technologies, which
otherwise may have progressed at a much slower pace. As we move towards a
reset and recovery across the healthcare sector, we are now seeing our
customers shift to their pre-COVID-19 production levels – but with
automation firmly at the heart of their operations to help streamline
and improve manufacturing, warehouse, and logistics operations.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Centauri Therapeutics Closes £24 million GBP Series A Investment Round
Investment from Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings REPAIR Impact Fun
Funding
will support continued advancement of Centauri’s antimicrobial
resistance research to identify novel therapeutic candidates using its
proprietary Alphamer platform
Appointment of Dr Johannes Zanzinger, Karen Lackey, Dr Camilla Petrycer Hansen to the Board of Directors.
More info >> |
|
 |
White Papers |
 |
|
What Your Clinical Study Design Reveals About Your Clinical Packaging Needs
PCI Pharma Services
As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)
20-21 June 2022, Berlin, Germany
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is
held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers
pharmaceutical companies, CMOs and CDMOs, governmental bodies together
with pharmaceutical equipment providers and service companies to discuss
the manufacturing and packaging processes of the pharmaceutical
industry. Among the participating companies are Bayer, Sandoz, Merck,
Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >> |
|
|
